Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-07-24 | Ziccum | Ziccum säkrar andra Feasibility-avtalet på två månader: VD-intervju på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-20 | Ziccum | Ziccums Q2-rapport - VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Ziccum | ZICCUM AB (publ) Interim report Q2 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-17 | Ziccum | Ziccum signs Evaluation Agreement for Feasibility Study with major global Pharmaceutical Corporation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Ziccum | Ziccum sponsors the Global mRNA-Based Therapeutics Summit, Boston MA, July 26-28 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Ziccum | Ziccum joint proposal not selected for detailed application in current CEPI Call | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-02 | Ziccum | Ziccum appoints senior biopharma executive as new CFO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Ziccum | Ziccum AB: BioStock Life Science Spring Summit med Ziccum | Pressreleaser | Visa Stäng |
|
||||
2023-05-30 | Ziccum | Ziccum AB: BioStock Life Science Spring Summit with Ziccum | Pressreleaser | Visa Stäng |
|
||||
2023-05-26 | Ziccum | Aerosol and inhalation authority Per Gerde joins Board of Directors of Ziccum AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-25 | Ziccum | Ziccum CEO to present at BioStock Life Science Spring Summit | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Ziccum | Kommuniké från årsstämma i Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-24 | Ziccum | Bulletin from the Annual General Meeting of Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | Ziccum | Strategin ger resultat med betald studie i samarbete med toppbolag: VD-intervju på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | Ziccum | Ziccum signs Evaluation Agreement with Biopharmaceutical Corporation focused on mRNA technologies | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-09 | Ziccum | Ziccums Q1-resultat: VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-08 | Ziccum | KOMPLETTERING TILL KALLELSEN TILL ÅRSSTÄMMA I ZICCUM AB (PUBL), ATT HÅLLAS DEN 24 MAJ 2023, KL. 11.00 I BOLAGETS LOKALER PÅ SCHEELEVÄGEN 22 I LUND | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Ziccum | Ziccum AB filing three patent applications as part of new, expanded strategy to strengthen patent protection | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-26 | Ziccum | ZICCUM AB (publ) releases Interim report Q1 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-24 | Ziccum | KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-20 | Ziccum | Ziccum reports positive results from drying of active mRNA and promising mRNA activity after powder reconstitution | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-17 | Ziccum | Ziccum to attend BIO-Europe Spring in Basel | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-10 | Ziccum | Ziccum AB joins innovative financial platform for Investor Relations management and European outreach | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-17 | Ziccum | ZICCUM AB (publ) releases Annual Report 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-01-27 | Ziccum | ZICCUM AB (publ) Year-end report Q4 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-23 | Ziccum | Ziccum submits Expression of Interest for CEPI funding | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-18 | Ziccum | Ziccum CEO to present at international mRNA Summit in Berlin | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-16 | Ziccum | Ziccum awarded 10 MSEK Eurostars funding for 3D-modeling and Digital twin project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-14 | Ziccum | Ziccum launches new, expanded website | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-08 | Ziccum | Ziccum signs agreement with Zurich University of Applied Sciences on advanced 3D-modeling project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-28 | Ziccum | Ziccums Q3-resultat: VD-uppdatering på svenska | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-27 | Ziccum | ZICCUM AB (publ) Interim report Q3 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Ziccum | Ziccum generates proof of successful drying of lipid nanoparticles in mRNA project | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-27 | Ziccum | Ziccum reopens application for CEPI funding on thermostable vaccines with new partner | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-23 | Ziccum | Ziccum receives results from evaluation study with leading Pharmaceutical Corporation | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-09-14 | Ziccum | Ziccum and Zurich University of Applied Sciences submit joint application for Eurostars funding | Analyser | Ladda ner | Visa Stäng |
Analyser |
Ziccum and Zurich University of Applied Sciences submit joint application for Eurostars fundingFollowing their agreed collaboration, Ziccum AB and the team from the ICP Institute of Computational Physics at the Zurich University of Applied Sciences’s School of Engineering (ZHAW) have now submitted an application to the Eurostars funding body. The proposed project will develop 3D modelling, and ultimately a Digital Twin, of LaminarPace (LAPA) that will accelerate development and scale-up and promote tech transfer, partnering and ultimately sales. The team from ZHAW, headed by Prof. Dr. Gernot Boiger, has collaborated with the Ziccum team at Lund to produce a detailed application for their joint project, which has already generated valuable data on LAPA – Ziccum’s unique unique ambient drying system that can dry vaccines and biologics at room temperature, producing robust dry formulations that require no refrigeration or freezing. In the first phase of the proposed project the teams plan to work on 3D modelling of LAPA’s flow, particle formulation and scale-out. A projected final phase aims to further develop the 3D modeling. Prof. Dr. Gernot Boiger, Head of Research Area Multiphysics Modelling and Imaging at the School of Engineering, ZHAW: “In this collaborative effort we haven’t just learned to work together seamlessly, we have also managed to compose a strong Eurostars proposal. This proposal will be the foundation for carrying out innovative R&D together over the coming years. I think that bringing the teams of Ziccum and ZHAW/ICP together has really worked well.” Ziccum CEO Ann Gidner: “We’re already hard at work with our great partners at ZHAW,who share our drive and commitment to this unique and much-needed drying technology. We believe this project will significantly strengthen and accelerate the development of LAPA, delivering insights into the unique properties of the particles LAPA can formulate, and accelerating its industrialization.” About LAPA: LAPA is Ziccum’s unique ambient drying system for vaccines and biologics. In the field of vaccines, LAPA formulates thermostable vaccines that can withstand elevated temperatures without requiring refrigeration or freezing. In the field of biologic drugs, LAPA meets the unmet need for an ambient drying method, drying delicate proteins and viruses at room temperature without the damaging effects of heat. This gives particles that typically retain robust structures and high API activity, making them thermostable – and highly valuable for novel formulation techniques. About Eurostars: Eurostars funds innovative collaborative R&D projects across 37 member countries, specializing in projects that partner SMEs with larger companies, universities and research organizations. Eurostars is co-funded by the EU Horizon 2020 Framework Programme and EUREKA, the world’s largest public network for international cooperation in R&D and innovation. For more information about Ziccum, please contact: |
||||
2022-09-01 | Ziccum | Ziccum on the move: company to attend major industry events across Europe in 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-23 | Ziccum | ZICCUM AB (publ) Interim report Q2 2022 | Analyser | Ladda ner | Visa Stäng |
|